Showing results (921-930 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|February 8, 2013
Building a competitive insurance system: Switzerland's strategy for managed-care healthcarePeter ZweifelPharmacoeconomics|June 9, 2012
Reimbursement decisions of the All Wales Medicines Strategy Group: influence of policy and clinical and economic factorsWarren G Linley, Dyfrig A HughesPharmacoeconomics|June 13, 2012
Duloxetine use in chronic low back pain: treatment patterns and costsJasmina I Ivanova, Howard G Birnbaum, Evan Kantor, et al.Pharmacoeconomics|April 13, 2002
Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthmaAlan J Zillich, Karen Blumenschein, Magnus Johannesson, et al.Pharmacoeconomics|April 4, 2002
Economic value of thrombolysis with adjunctive abciximab in patients with subacute peripheral arterial occlusionStephan H Duda, Gunnar Tepe, Mohan Bala, et al.Pharmacoeconomics|December 18, 2009
Should financial incentives be used to differentially reward 'me-too' and innovative drugs?Brita PekarskyPharmacoeconomics|December 18, 2009
The cost and incidence of prescribing errors among privately insured HIV patientsFred J Hellinger, William E EncinosaPharmacoeconomics|November 10, 2005
Antiviral agents for influenza: a comparison of cost-effectiveness dataLarry D Lynd, Ron Goeree, Bernie J O'BrienPharmacoeconomics|November 10, 2005
Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literatureRalph P Insinga, Erik J Dasbach, Elamin H ElbashaPharmacoeconomics|November 10, 2005
The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experimentAndrew Lloyd, Emma McIntosh, Martin PricePageof 336